T1	Participants 157 190	patients with atrial fibrillation
T2	Participants 432 473	1,146 patients with AF and risk of stroke
T3	Participants 835 894	Mean age was 65 +/- 8.7 years and 64.4% were warfarin-naÃ¯ve
